Senior Director, Global Regulatory Policy Development
Pfizer
Judith holds a B.Sc, (hons), in Microbiology from the University of Bristol UK. She has 27 years’ experience in global regulatory strategy where she oversaw the development and registration of multiple products both small molecule and biologics across a range of therapeutic areas with US FDA, EMA and emerging markets. Since 2016 her role has been dedicated to regulatory policy where she leverages her regulatory development knowledge and advocacy skills to help solve current regulatory challenges.
As acting global regulatory policy lead for Accumulus Synergy she is passionate about transforming the approach to regulatory submissions via a cloud- based platform. She is also an active member of IFPMA’s regulatory science committee and represents IFPMA on ICH’s Management Committee, Assembly and Industry Executive Council. Her past achievements also include driving thought leadership on biologics and biosimilars policy. She is passionate about regulatory system strengthening, reliance, science- led regulation, digitalisation and global convergence.
She joined Pfizer in 2007 and has worked in regulatory strategy, public affairs and regulatory policy. In 2016 she became head of the regulatory policy team for Pfizer’s essential health products including biosimilars. In January 2019 she became responsible for global policy development focusing on regulatory science advocacy and strategic communications.